国内PD-1抑制剂赛道已从早期靶点扎堆的适应症红海竞争，正式转向以给药效率与临床体验为核心的差异化新阶段。相较于传统静脉输注类PD-1产品需多次往返医院、耗费数小时给药时长的不便，多款创新剂型凭借更优的给药方案实现体验升级：部分皮下注射PD-1仅需数 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results